Table 1.
Trial schedule
| Operation and perioperative data collection | |||||||
| Preoperative | Postoperative follow-up | ||||||
| Screen | Baseline | 1 | 2 | 3† | 4† | 5† | |
| 30 days postop | 6 weeks postop | 3 months after follow-up 2 | 6 months after follow-up 2 | 9 months after follow-up 2 | |||
| Screen/eligibility | x | ||||||
| Consent | x | ||||||
| Demographics and history | x | ||||||
| Randomisation | x | ||||||
| EORTC QLQ-C30* | x | x | x | x | x | ||
| EORTC QLQ-OV28* | x | x | x | x | x | ||
| EQ-5D-5L | x | x | x | x | x | ||
| Adverse events | x | ||||||
| Resource use questionnaire | x | x | x | ||||
| Qualitative interviews | x | x | |||||